COMPASS PATHWAYS PLC

Charts COMPASS Pathways plc

Stocks

CMPS

US20451W1018

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 18/09/2026 am IST			5-day change	1st Jan Change
15.00 ^USD	+8.70%		+5.49%	+117.39%

09/09	Compass Pathways Reports New 52-Week Topline Open-Label Data From Phase 3 COMP005 Trial Demonstrating Additional Benefit From Another COMP360 Dose In Part C Extending Durability Out To 1 Year	CI
06/08	B. Riley Adjusts COMPASS Pathways Price Target to $22 From $17, Maintains Buy Rating	MT

Chart: Technical Analysis

NasdaqUSD

Markets		Quality
Nasdaq	CMPS	Delayed
CBOE	CMPS	Real-time
Tradegate	5Y6	Real-time
Mexican S.E.	CMPS N	End-of-day quote
Boerse Muenchen	5Y6	Real-time
Deutsche Boerse AG	5Y6	Delayed
Börse Stuttgart	5Y6	Delayed

ProRealTime Chart

Technical analysis trends

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bullish	Bullish
Resistance	15.17	15.17	20.07
Spread/Res.	-1.12%	-1.12%	-25.26%
Spread/Supp.	+13.81%	+71.43%	+66.48%
Support	13.18	8.75	9.01

MarketScreener's Technical Analysis Ratings

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes

Stock Market
Stocks
CMPS Stock
Charts COMPASS Pathways plc

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!